Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary

  Prostate Cancer

  Free Subscription


17.02.2020

1 Am J Surg Pathol
2 BJU Int
1 Br J Cancer
1 Eur J Radiol
3 Eur Urol
9 Int J Radiat Oncol Biol Phys
2 Int J Urol
1 J Magn Reson Imaging
1 J Nucl Med
3 Nat Rev Urol
2 PLoS Genet
3 PLoS One
1 Prostate
3 Urol Int


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg Pathol

  1. LOTAN TL, Tomlins SA, Bismar TA, Van der Kwast TH, et al
    Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate Cancer.
    Am J Surg Pathol. 2020 Feb 10. doi: 10.1097/PAS.0000000000001450.
    PubMed     Text format     Abstract available


    BJU Int

  2. SOOD A, Keeley J, Palma-Zamora I, Dalela D, et al
    Extended pelvic lymph-node dissection is independently associated with improved overall survival in prostate cancer patients at high-risk for lymph-node invasion.
    BJU Int. 2020 Feb 11. doi: 10.1111/bju.15034.
    PubMed     Text format     Abstract available

  3. MAMAWALA MK, Meyer A, Landis P, Macura KJ, et al
    Utility of multiparametric MRI in the risk stratification of men with Grade Group 1 prostate cancer on active surveillance.
    BJU Int. 2020 Feb 10. doi: 10.1111/bju.15033.
    PubMed     Text format     Abstract available


    Br J Cancer

  4. LEVESQUE E, Labriet A, Hovington H, Allain EP, et al
    Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression.
    Br J Cancer. 2020 Feb 12. pii: 10.1038/s41416-020-0749.
    PubMed     Text format     Abstract available


    Eur J Radiol

  5. CHEN Z, Xue Y, Zhang Z, Li W, et al
    The performance of intravoxel-incoherent motion diffusion-weighted imaging derived hypoxia for the risk stratification of prostate cancer in peripheral zone.
    Eur J Radiol. 2020;125:108865.
    PubMed     Text format     Abstract available


    Eur Urol

  6. DAVIS JW
    Re: Medium-term Oncologic Outcomes in a Large Cohort of Men Treated with Focal or Hemi-ablation Using High-intensity Focused Ultrasonography for Primary Localized Prostate Cancer.
    Eur Urol. 2020 Feb 4. pii: S0302-2838(20)30067.
    PubMed     Text format    

  7. MONTORSI F, Fossati N, Gandaglia G, Briganti A, et al
    Re: Aurelie De Bruycker, Elise De Bleser, Karel Decaestecker, et al. Nodal Oligorecurrent Prostate Cancer: Anatomic Pattern of Possible Treatment Failure in Relation to Elective Surgical and Radiotherapy Treatment Templates. Eur Urol 2019;75:826-33: N
    Eur Urol. 2020 Feb 6. pii: S0302-2838(20)30068.
    PubMed     Text format    

  8. BELTRAN H, Morris MJ
    Docetaxel for Early Prostate Cancer: What Have We Learned?
    Eur Urol. 2020 Feb 6. pii: S0302-2838(20)30064.
    PubMed     Text format    


    Int J Radiat Oncol Biol Phys

  9. VITZTHUM LK, Park H, Zakeri K, Heide ES, et al
    Risk of Pelvic Fracture With Radiation Therapy in Older Patients.
    Int J Radiat Oncol Biol Phys. 2020;106:485-492.
    PubMed     Text format     Abstract available

  10. NOSRATI R, Wronski M, Tseng CL, Chung H, et al
    Postimplant Dosimetry of Permanent Prostate Brachytherapy: Comparison of MRI-Only and CT-MRI Fusion-Based Workflows.
    Int J Radiat Oncol Biol Phys. 2020;106:206-215.
    PubMed     Text format     Abstract available

  11. FULLER D, Wurzer J, Shirazi R, Bridge S, et al
    Retreatment for Local Recurrence of Prostatic Carcinoma After Prior Therapeutic Irradiation: Efficacy and Toxicity of HDR-Like SBRT.
    Int J Radiat Oncol Biol Phys. 2020;106:291-299.
    PubMed     Text format     Abstract available

  12. CORNELL M, Kaderka R, Hild SJ, Ray XJ, et al
    Noninferiority Study of Automated Knowledge-Based Planning Versus Human-Driven Optimization Across Multiple Disease Sites.
    Int J Radiat Oncol Biol Phys. 2020;106:430-439.
    PubMed     Text format     Abstract available

  13. SAMPATH S, Frankel P, Vecchio BD, Ruel N, et al
    Stereotactic Body Radiation Therapy to the Prostate Bed: Results of a Phase 1 Dose-Escalation Trial.
    Int J Radiat Oncol Biol Phys. 2020;106:537-545.
    PubMed     Text format     Abstract available

  14. RODRIGUEZ-LOPEZ JL, Beriwal S
    Nodal Recurrence From Prostate Adenocarcinoma: Curable or Incurable?
    Int J Radiat Oncol Biol Phys. 2020;106:236-237.
    PubMed     Text format    

  15. HAGAN M, Kapoor R, Michalski J, Sandler H, et al
    VA-Radiation Oncology Quality Surveillance Program.
    Int J Radiat Oncol Biol Phys. 2020;106:639-647.
    PubMed     Text format     Abstract available

  16. DINH TT, Lee HJ Jr, Macomber MW, Apisarnthanarax S, et al
    Rectal Hydrogel Spacer Improves Late Gastrointestinal Toxicity Compared To Rectal Balloon Immobilization After Proton Beam Radiotherapy For Localized Prostate Cancer: A Retrospective Observational Study.
    Int J Radiat Oncol Biol Phys. 2020 Feb 5. pii: S0360-3016(20)30152.
    PubMed     Text format     Abstract available

  17. ONG WL, Foroudi F, Milne RL, Millar JL, et al
    Variation in the Use of Single- Versus Multifraction Palliative Radiation Therapy for Bone Metastases in Australia.
    Int J Radiat Oncol Biol Phys. 2020;106:61-66.
    PubMed     Text format     Abstract available


    Int J Urol

  18. SHIOTA M, Onozawa M, Hinotsu S, Eto M, et al
    Family history in primary hormone therapy for prostate cancer: Analysis from a community-based multi-institutional Japan-wide database.
    Int J Urol. 2020 Feb 10. doi: 10.1111/iju.14184.
    PubMed     Text format     Abstract available

  19. KITAGAWA Y
    Editorial Comment to Family history in primary hormone therapy for prostate cancer: Analysis from a community-based multi-institutional Japan-wide database.
    Int J Urol. 2020 Feb 10. doi: 10.1111/iju.14198.
    PubMed     Text format    


    J Magn Reson Imaging

  20. BYUN J, Park KJ, Kim MH, Kim JK, et al
    Direct Comparison of PI-RADS Version 2 and 2.1 in Transition Zone Lesions for Detection of Prostate Cancer: Preliminary Experience.
    J Magn Reson Imaging. 2020 Feb 11. doi: 10.1002/jmri.27080.
    PubMed     Text format     Abstract available


    J Nucl Med

  21. LIU C, Liu T, Zhang Z, Zhang N, et al
    PSMA PET/CT and standard plus PET/CT-Ultrasound fusion targeted prostate biopsy can diagnose clinically significant prostate cancer in men with previous negative biopsies.
    J Nucl Med. 2020 Feb 7. pii: jnumed.119.235333. doi: 10.2967/jnumed.119.235333.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  22. ZAORSKY NG, Kishan AU
    Salvage therapy at biochemical recurrence of prostate cancer.
    Nat Rev Urol. 2020 Feb 12. pii: 10.1038/s41585-020-0290.
    PubMed     Text format    

  23. THOMAS T
    Automated systems comparable to expert pathologists for prostate cancer Gleason grading.
    Nat Rev Urol. 2020 Feb 13. pii: 10.1038/s41585-020-0294.
    PubMed     Text format    

  24. MAUGHAN BL, Antonarakis ES
    Does sequencing order of antiandrogens in prostate cancer matter?
    Nat Rev Urol. 2020 Feb 11. pii: 10.1038/s41585-020-0289.
    PubMed     Text format    


    PLoS Genet

  25. OLSON A, Le V, Aldahl J, Yu EJ, et al
    The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression.
    PLoS Genet. 2019;15:e1008451.
    PubMed     Text format     Abstract available

  26. YUAN J, Kensler KH, Hu Z, Zhang Y, et al
    Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry.
    PLoS Genet. 2020;16:e1008641.
    PubMed     Text format     Abstract available


    PLoS One

  27. SIROHI D, Devine P, Grenert JP, van Ziffle J, et al
    TP53 structural variants in metastatic prostatic carcinoma.
    PLoS One. 2019;14:e0218618.
    PubMed     Text format     Abstract available

  28. LUCAS AR, Bitting RL, Fanning J, Isom S, et al
    Trajectories in muscular strength and physical function among men with and without prostate cancer in the health aging and body composition study.
    PLoS One. 2020;15:e0228773.
    PubMed     Text format     Abstract available

  29. RABIN-COURT A, Rodrigues MR, Zhang XM, Perry RJ, et al
    Obesity-associated, but not obesity-independent, tumors respond to insulin by increasing mitochondrial glucose oxidation.
    PLoS One. 2019;14:e0218126.
    PubMed     Text format     Abstract available


    Prostate

  30. MARLIN R, Creoff M, Merle S, Jean-Marie-Flore M, et al
    Mutation HOXB13 c.853delT in Martinican prostate cancer patients.
    Prostate. 2020 Feb 10. doi: 10.1002/pros.23960.
    PubMed     Text format     Abstract available


    Urol Int

  31. ANTONELLI A, Palumbo C, Noale M, Porreca A, et al
    Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study).
    Urol Int. 2019;103:8-18.
    PubMed     Text format     Abstract available

  32. HODHOD A, Oquendo F, Nour H, Kelly R, et al
    The ex vivo and in vivo Characteristics of New DrillCutTM Prostate Morcellator after Holmium Laser Enucleation of the Prostate: A Pilot Study.
    Urol Int. 2019;103:95-101.
    PubMed     Text format     Abstract available

  33. ZALESKY M, Stejskal J, Adamcova V, Hrbacek J, et al
    Use of Prostate Specific Antigen Density Combined with Multiparametric Magnetic Resonance Imaging Improves Triage for Prostate Biopsy.
    Urol Int. 2019;103:33-40.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: